AHA Coding Clinic® for HCPCS - 2010 Quarter 3; FOR your INFORMATION
CMS Updates Guidance on the Reporting of Modifier JW for Discarded Drugs Not Administered
CMS continues to instruct physicians, hospitals or other providers or suppliers to append modifier JW, Discarded drug not administered , should it be necessary to discard the remainder of a single use vial or other single use package after administering a dose/quantity of the drug or biological to a Medicare patient. Modifier JW identifies the unused drug or biologicals from single use vials or single use packages that are appropriately discarded. For example, a single use vial that is labeled to contain 100 units of a drug has 95 units administered to the patient and 5 units discarded. The 95...
Subscribe or sign in to view the full article.
Article Overview
This article explains CMS guidance on the reporting of modifier JW in situations involving discarded amounts from single-use vials or packages. It is relevant to physicians, hospitals, and other providers or suppliers that bill Medicare for drugs or biologicals and need to understand the general reporting framework discussed by CMS.
Why This Topic Matters
Accurate reporting of discarded drug amounts affects billing compliance for Medicare claims involving single-use drug packaging. The article helps providers understand the general CMS guidance covered in the premium content without revealing the full instructional details.
What You Will Learn
- How CMS addresses reporting of discarded drug or biological amounts
- Which provider types the guidance is directed toward
- The general billing context for single-use vials and packages
- Why discarded quantities can affect Medicare claim reporting
Who Should Read This
- Physicians
- Hospitals
- Other providers and suppliers
- Medical coders
- Billing staff
- Compliance teams
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com